Enamine Ltd, founded in 1991, is a leading global provider of Screening Compounds, Building Blocks, and Fragments for research programs in the pharmaceutical and biotech industries. With over 15 years of experience, Enamine has developed a comprehensive range of R&D services to meet the evolving needs of its customers. Enamine's chemical services include custom synthesis, compound library design, hit follow-up support, and lead optimization.

In addition, the company is expanding its biology services, offering reliable bioanalytical services, molecular screening programs, and other biological studies. Driven by its commitment to being a one-stop-shop solution for the Life Science industries, Enamine has a team of over 500 highly skilled chemists, biologists, and engineers. Its headquarters in Kyiv, Ukraine, span 5 acres and house multiple buildings for labs, compound stock facilities, and business departments.

The company also has stock facilities in the USA and Europe, along with authorized representatives in Asia. Enamine is dedicated to supporting research and innovation in the field of drug discovery, helping its clients accelerate the development of new therapeutic solutions